Request Demo
Last update 23 Jan 2025
Olmesartan Medoxomil/Amlodipine orotate
Last update 23 Jan 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Sevisartan |
Target |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (30 Oct 2014), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC25H29ClN4O9 |
InChIKeyDBGOBQCYSPDGNR-UHFFFAOYSA-N |
CAS Registry914941-70-1 |
View All Structures (2)
Related
1
Clinical Trials associated with Olmesartan Medoxomil/Amlodipine orotateNCT02058472
An Open Label, Randomized, Single-dose Crossover Study to Evaluate the Pharmacokinetic/Pharmacodynamic Characteristics and Safety Following Administration of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers
100 Clinical Results associated with Olmesartan Medoxomil/Amlodipine orotate
Login to view more data
100 Translational Medicine associated with Olmesartan Medoxomil/Amlodipine orotate
Login to view more data
100 Patents (Medical) associated with Olmesartan Medoxomil/Amlodipine orotate
Login to view more data
100 Deals associated with Olmesartan Medoxomil/Amlodipine orotate
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Essential Hypertension | KR | 30 Oct 2014 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free